Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2013/07/003817
CTRI/2013/07/003817
Completed
Phase 4

A multicentric, prospective, observational Registry for assessment of clinical outcomes in Indian adult (more than 18 years of age), 18-50 and more than 65 years inpatients undergoing surgery more than 2 hrs duration during Suprane anaesthesia - RISE

Baxter India Pvt Ltd0 sites400 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- anesthesia for inpatient surgery in adults

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- anesthesia for inpatient surgery in adults
Sponsor
Baxter India Pvt Ltd
Enrollment
400
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Pms

Investigators

Sponsor
Baxter India Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • •(1\)Male or female (non\-pregnant, non\-lactating) who is \> 18 years of age, either 18\-50 years or \>65 years
  • •(2\)Are American Society of Anesthesiologists physical status of I, II, or III
  • •(3\)Scheduled to receive desflurane as the general anesthetic for a surgical procedure with an anticipated duration of 120 minutes or longer
  • •(4\)Expected to be transferred to the PACU after surgery or Planned extubation in operative room
  • •(5\)Has provided written informed consent (unless the responsible IRB/IEC has granted a waiver of the requirement for informed consent

Exclusion Criteria

  • •(1\)Age group 51\-64 years of age. Known or suspected genetic susceptibility to malignant hyperthermia
  • •(2\)Patient in whom general anesthesia is contraindicated
  • •(3\)Known sensitivity to desflurane or to other halogenated agents
  • •(4\)Patients who are pregnant or lactating

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Phase 4
This study is conducted to collect real world data on effectiveness and safety of Bivalirudin, a blood thinner, in Indian patients undergoing angioplastyHealth Condition 1: null- Acute Coronary Syndrome (ACS) patient population undergoing percutaneous coronary intervention
CTRI/2014/03/004452Institute of Cardio Vascular Diseases1,500
Not yet recruiting
Phase 4
To assess the safety and performance of the Myval™ Transcatheter Heart Valve System (THV) in real-world settings.
CTRI/2023/10/059323Meril Diagnostics Private Limited
Completed
Not Applicable
An observational, prospective, multi-centre, natural history study of patients with mucopolysaccharidosis type IIIAor Mucopolysaccharidosis type III (MPS III)Sanfilippo syndrome10083624
NL-OMON46191ysogene SA5
Completed
Not Applicable
An Observational prospective Multicenter registry study on Outcomes of peripheral arTErial disease patieNts treated by AngioplaSty tHerapy in aortoIliac arteryPeripheral artery disease
JPRN-UMIN000013849Research group on endovascular treatment in aortiliac artery1,500
Recruiting
Not Applicable
Metastatic ColoRectal cancer India RegistryHealth Condition 1: C189- Malignant neoplasm of colon, unspecified
CTRI/2022/07/043968Dr Reddys Laboratories